http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 02 Sep 2026 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Maze+Therapeutics+to+Participate+in+Three+Upcoming+Investor+Conferences/27015442.html <p align="left">SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced that company management will participate in three upcoming investor conferences:</p> <ul><li>Wells Fargo 21^st Annual Healthcare Conference; fireside chat on Wednesday, September 9, 2026, at 9:30 a.m. ET</li><li>Citi 2026 Biopharma Back to School Summit; fireside chat on Thursday, September 10, 2026, at 2:20 p.m. ET</li><li>H.C. Wainwright 28^th Annual Global Investment Conference; fireside chat on Tuesday, September 15, 2026, at 9:00 a.m. ET<br /><br /></li></ul> http://www.streetinsider.com/Press+Releases/Maze+Therapeutics+to+Participate+in+Three+Upcoming+Investor+Conferences/27015442.html Wed, 02 Sep 2026 07:00:00 -0400 MAZE http://www.streetinsider.com/Globe+Newswire/Maze+Therapeutics+to+Participate+in+Three+Upcoming+Investor+Conferences/27015442.html <p align="left">SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced that company management will participate in three upcoming investor conferences:</p> <ul><li>Wells Fargo 21^st Annual Healthcare Conference; fireside chat on Wednesday, September 9, 2026, at 9:30 a.m. ET</li><li>Citi 2026 Biopharma Back to School Summit; fireside chat on Thursday, September 10, 2026, at 2:20 p.m. ET</li><li>H.C. Wainwright 28^th Annual Global Investment Conference; fireside chat on Tuesday, September 15, 2026, at 9:00 a.m. ET<br /><br /></li></ul> http://www.streetinsider.com/Globe+Newswire/Maze+Therapeutics+to+Participate+in+Three+Upcoming+Investor+Conferences/27015442.html Wed, 02 Sep 2026 07:00:00 -0400 MAZE http://www.streetinsider.com/New+Coverage/TD+Cowen+Assumes+Maze+Therapeutics+%28MAZE%29+at+Buy/26962956.html <p>TD Cowen analyst Phil assumes coverage on Maze Therapeutics (NASDAQ: MAZE) with a Buy rating.</p> <p>For an analyst ratings summary and ratings history on Maze Therapeutics <a href="http://www.streetinsider.com/rating_history.php?q=MAZE">click here</a>. For more ratings news on Maze Therapeutics <a href="http://www.streetinsider.com/stock_lookup_news.php?q=MAZE&amp;type=analyst">click here</a>.</p> <p>Shares of Maze Therapeutics closed at $29.43 yesterday.</p> http://www.streetinsider.com/New+Coverage/TD+Cowen+Assumes+Maze+Therapeutics+%28MAZE%29+at+Buy/26962956.html Sat, 22 Aug 2026 07:55:28 -0400 MAZE http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Kornowski+Sophie/26938668.html si-local-file:///var/storage/secattach/20260817/26938668.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Kornowski+Sophie/26938668.html Mon, 17 Aug 2026 16:52:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Kornowski+Sophie/26938668.html si-local-file:///var/storage/secattach/20260817/26938668.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Kornowski+Sophie/26938668.html Mon, 17 Aug 2026 16:52:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Johnson+Paula+A/26938655.html si-local-file:///var/storage/secattach/20260817/26938655.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Johnson+Paula+A/26938655.html Mon, 17 Aug 2026 16:51:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Johnson+Paula+A/26938655.html si-local-file:///var/storage/secattach/20260817/26938655.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Johnson+Paula+A/26938655.html Mon, 17 Aug 2026 16:51:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Kornowski+Sophie/26938626.html si-local-file:///var/storage/secattach/20260817/26938626.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Kornowski+Sophie/26938626.html Mon, 17 Aug 2026 16:49:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Kornowski+Sophie/26938626.html si-local-file:///var/storage/secattach/20260817/26938626.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Kornowski+Sophie/26938626.html Mon, 17 Aug 2026 16:49:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Johnson+Paula+A/26938567.html si-local-file:///var/storage/secattach/20260817/26938567.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Johnson+Paula+A/26938567.html Mon, 17 Aug 2026 16:46:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Johnson+Paula+A/26938567.html si-local-file:///var/storage/secattach/20260817/26938567.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Johnson+Paula+A/26938567.html Mon, 17 Aug 2026 16:46:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13/26938164.html si-local-file:///var/storage/secattach/20260817/26938164.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13/26938164.html Mon, 17 Aug 2026 16:17:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13/26938164.html si-local-file:///var/storage/secattach/20260817/26938164.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13/26938164.html Mon, 17 Aug 2026 16:17:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Bernstein+Harold/26932285.html si-local-file:///var/storage/secattach/20260814/26932285.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Bernstein+Harold/26932285.html Fri, 14 Aug 2026 16:55:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Bernstein+Harold/26932285.html si-local-file:///var/storage/secattach/20260814/26932285.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Maze+Therapeutics%2C+Inc.+++For%3A+Aug+13++Filed+by%3A+Bernstein+Harold/26932285.html Fri, 14 Aug 2026 16:55:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Maze+Therapeutics%2C+Inc.++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26931388.html si-local-file:///var/storage/secattach/20260814/26931388.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Maze+Therapeutics%2C+Inc.++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26931388.html Fri, 14 Aug 2026 16:31:00 -0400 MAZE O.70187309 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Maze+Therapeutics%2C+Inc.++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26931388.html si-local-file:///var/storage/secattach/20260814/26931388.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Maze+Therapeutics%2C+Inc.++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26931388.html Fri, 14 Aug 2026 16:31:00 -0400 MAZE O.70187309 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html <p>Maze Therapeutics, Inc. (Nasdaq: MAZE) has appointed Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its board of directors, according to a company statement.</p> <p>Dr. Johnson brings more than 30 years of clinical and research experience in cardiology. She has served as president of Wellesley College since 2016 and currently sits on the board of directors of Johnson & Johnson. She previously founded and led the Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital and held faculty positions at Harvard Medical School and the Harvard School of Public Health.</p> <p>Dr. Kornowski has more than 35 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html Thu, 13 Aug 2026 16:42:41 -0400 A.01928742 A.28191817 A.35954321 A.40151759 A.40462110 A.40976481 MAZE O.00050368 O.00222506 O.02103229 O.20737027 O.22770699 O.47803387 O.70187309 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html <p>Maze Therapeutics, Inc. (Nasdaq: MAZE) has appointed Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its board of directors, according to a company statement.</p> <p>Dr. Johnson brings more than 30 years of clinical and research experience in cardiology. She has served as president of Wellesley College since 2016 and currently sits on the board of directors of Johnson & Johnson. She previously founded and led the Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital and held faculty positions at Harvard Medical School and the Harvard School of Public Health.</p> <p>Dr. Kornowski has more than 35 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html Thu, 13 Aug 2026 16:42:41 -0400 A.01928742 A.28191817 A.35954321 A.40151759 A.40462110 A.40976481 MAZE O.00050368 O.00222506 O.02103229 O.20737027 O.22770699 O.47803387 O.70187309 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html <p>Maze Therapeutics, Inc. (Nasdaq: MAZE) has appointed Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its board of directors, according to a company statement.</p> <p>Dr. Johnson brings more than 30 years of clinical and research experience in cardiology. She has served as president of Wellesley College since 2016 and currently sits on the board of directors of Johnson & Johnson. She previously founded and led the Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital and held faculty positions at Harvard Medical School and the Harvard School of Public Health.</p> <p>Dr. Kornowski has more than 35 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html Thu, 13 Aug 2026 16:42:41 -0400 A.01928742 A.28191817 A.35954321 A.40151759 A.40462110 A.40976481 MAZE O.00050368 O.00222506 O.02103229 O.20737027 O.22770699 O.47803387 O.70187309 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html <p>Maze Therapeutics, Inc. (Nasdaq: MAZE) has appointed Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its board of directors, according to a company statement.</p> <p>Dr. Johnson brings more than 30 years of clinical and research experience in cardiology. She has served as president of Wellesley College since 2016 and currently sits on the board of directors of Johnson & Johnson. She previously founded and led the Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital and held faculty positions at Harvard Medical School and the Harvard School of Public Health.</p> <p>Dr. Kornowski has more than 35 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html Thu, 13 Aug 2026 16:42:41 -0400 A.01928742 A.28191817 A.35954321 A.40151759 A.40462110 A.40976481 MAZE O.00050368 O.00222506 O.02103229 O.20737027 O.22770699 O.47803387 O.70187309 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html <p>Maze Therapeutics, Inc. (Nasdaq: MAZE) has appointed Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its board of directors, according to a company statement.</p> <p>Dr. Johnson brings more than 30 years of clinical and research experience in cardiology. She has served as president of Wellesley College since 2016 and currently sits on the board of directors of Johnson & Johnson. She previously founded and led the Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital and held faculty positions at Harvard Medical School and the Harvard School of Public Health.</p> <p>Dr. Kornowski has more than 35 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html Thu, 13 Aug 2026 16:42:41 -0400 A.01928742 A.28191817 A.35954321 A.40151759 A.40462110 A.40976481 MAZE O.00050368 O.00222506 O.02103229 O.20737027 O.22770699 O.47803387 O.70187309 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html <p>Maze Therapeutics, Inc. (Nasdaq: MAZE) has appointed Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its board of directors, according to a company statement.</p> <p>Dr. Johnson brings more than 30 years of clinical and research experience in cardiology. She has served as president of Wellesley College since 2016 and currently sits on the board of directors of Johnson & Johnson. She previously founded and led the Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital and held faculty positions at Harvard Medical School and the Harvard School of Public Health.</p> <p>Dr. Kornowski has more than 35 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html Thu, 13 Aug 2026 16:42:41 -0400 A.01928742 A.28191817 A.35954321 A.40151759 A.40462110 A.40976481 MAZE O.00050368 O.00222506 O.02103229 O.20737027 O.22770699 O.47803387 O.70187309 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html <p>Maze Therapeutics, Inc. (Nasdaq: MAZE) has appointed Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its board of directors, according to a company statement.</p> <p>Dr. Johnson brings more than 30 years of clinical and research experience in cardiology. She has served as president of Wellesley College since 2016 and currently sits on the board of directors of Johnson & Johnson. She previously founded and led the Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital and held faculty positions at Harvard Medical School and the Harvard School of Public Health.</p> <p>Dr. Kornowski has more than 35 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html Thu, 13 Aug 2026 16:42:41 -0400 A.01928742 A.28191817 A.35954321 A.40151759 A.40462110 A.40976481 MAZE O.00050368 O.00222506 O.02103229 O.20737027 O.22770699 O.47803387 O.70187309 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html <p>Maze Therapeutics, Inc. (Nasdaq: MAZE) has appointed Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its board of directors, according to a company statement.</p> <p>Dr. Johnson brings more than 30 years of clinical and research experience in cardiology. She has served as president of Wellesley College since 2016 and currently sits on the board of directors of Johnson & Johnson. She previously founded and led the Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital and held faculty positions at Harvard Medical School and the Harvard School of Public Health.</p> <p>Dr. Kornowski has more than 35 http://www.streetinsider.com/Board+Changes/Maze+Therapeutics+adds+two+directors+with+clinical+and+pharma+backgrounds/26922201.html Thu, 13 Aug 2026 16:42:41 -0400 A.01928742 A.28191817 A.35954321 A.40151759 A.40462110 A.40976481 MAZE O.00050368 O.00222506 O.02103229 O.20737027 O.22770699 O.47803387 O.70187309